â– LECTURE OVERVIEW: Acute Rheumatic Fever (ARF) is an autoimmune, post-infectious inflammatory sequela triggered selectively by Streptococcus pyogenes (Group A Beta-Hemolytic Streptococcus, GAS) pharyngitis.
â– IMMUNOPATHOGENIC DETAILS:
1. M Protein (Antiphagocytic): S. pyogenes expresses M Protein, a coiled-coil alpha-helical protein that projects from the cell membrane, preventing phagocytosis by binding fibrinogen and inhibiting complement.
2. Epitopic Mimicry: The structural epitopes of M Protein are highly homologous to human coiled-coil proteins, specifically alpha-myosin and sarcolemma proteins in cardiac tissue, as well as joint and brain antigens.
3. Trans-Activation of B-Cells: The host immune system mounts a vigorous humoral response against the streptococcal M antigen, generating Anti-M antibodies.
4. Autoimmune Damage: These cross-react with cardiac self-antigens, activating the classical complement cascade and recruiting macrophages to healthy cardiac tissue, causing myocarditis, endocarditis, and pericarditis (pancarditis).
â– SPECIAL CLINICAL POPULATIONS & METABOLIC DEVIATIONS:
Infants display higher body water ratios and immature renal filtration capacity, whereas geriatric cohorts exhibit reduced physiologic reserves, progressive heart/renal decline, and polypharmacy interactions.
â– CLINICAL REGISTRY INSIGHTS:
Patient registry reviews depict high clinical validity in diverse populations, indicating highly correlated trends of symptom development and treatment responsiveness.
[HY-BOARD-1014]
🌟 Dynamic Clinical Key:
ARF develops 2-4 weeks after untreated streptococcal pharyngitis (never skin infections/impetigo). Diagnosed via the Jones criteria (joints arthritis, heart carditis, subcutaneous nodules, erythema marginatum, Sydenham chorea). Early treatment of GAS with Penicillin completely prevents ARF. Adjust weight-based dosing for pediatric cohorts and use the 'start low and go slow' approach for seniors. Assess demographic representation when applying trial results to real-world patients.